These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3485584)

  • 61. Validating an empiric sulfadiazine-trimethoprim dosage regimen for treatment of Escherichia coli and Staphylococcus delphini infections in mink (Neovison vison).
    Ronaghinia AA; Nikolaisen NK; Hansen SG; Poulsen HH; Frandsen HL; Struve T; Toutain PL; Damborg P
    J Vet Pharmacol Ther; 2021 Jan; 44(1):93-106. PubMed ID: 32924166
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Co-trifamole (Co-Fram).
    Drug Ther Bull; 1983 Mar; 21(5):19-20. PubMed ID: 6839969
    [No Abstract]   [Full Text] [Related]  

  • 63. Serum and skin concentrations after multiple-dose oral administration of trimethoprim-sulfadiazine in dogs.
    Pohlenz-Zertuche HO; Brown MP; Gronwall R; Kunkle GA; Merritt K
    Am J Vet Res; 1992 Jul; 53(7):1273-6. PubMed ID: 1497202
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of sulfadiazine/trimethoprim in neonatal male calves: effect of age and penetration into cerebrospinal fluid.
    Shoaf SE; Schwark WS; Guard CL
    Am J Vet Res; 1989 Mar; 50(3):396-403. PubMed ID: 2930028
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The biotransformation of sulfadimethoxine, sulfadimidine, sulfamethoxazole, trimethoprim and aditoprim by primary cultures of pig hepatocytes.
    Mengelers MJ; Kleter GA; Hoogenboom LA; Kuiper HA; Van Miert AS
    J Vet Pharmacol Ther; 1997 Feb; 20(1):24-32. PubMed ID: 9049946
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Significance of the sulfonamide component for the clinical efficacy of trimethoprim-sulfonamide combinations.
    Burman LG
    Scand J Infect Dis; 1986; 18(2):89-99. PubMed ID: 3518051
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics of newer combination of sulpha & trimethoprim.
    Seth SD; Malhotra KK; Rao A; Gupta M
    Indian J Med Res; 1983 Jul; 78():118-25. PubMed ID: 6642592
    [No Abstract]   [Full Text] [Related]  

  • 68. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.
    Ortengren B; Magni L; Bergan T
    Infection; 1979; 7 Suppl 4():S371-81. PubMed ID: 511351
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of pectin and kaolin on bioavailability of co-trimoxazole suspension.
    Gupta KC; Desai NK; Satoskar RS; Gupta C; Goswami SN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):320-1. PubMed ID: 3497885
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparative study of the pharmacokinetics of intravenous and oral trimethoprim/sulfadiazine formulations in the horse.
    van Duijkeren E; Vulto AG; Sloet van Oldruitenborghoosterbaan MM; Mevius DJ; Kessels BG; Breukink HJ; van Miert AS
    J Vet Pharmacol Ther; 1994 Dec; 17(6):440-6. PubMed ID: 7707489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections.
    Quintiliani R; Levitz RE; Nightingale CH
    Rev Infect Dis; 1987; 9 Suppl 2():S160-7. PubMed ID: 3554454
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Inhibitor and bactericidal activity of the serum and urine of subjects treated with trimethoprim, sulfadiazine and with a combination of the 2 drugs, cotrimazine].
    Concia E; Cruciani M; Monzillo V; Castiglioni G; Cerutti R
    G Ital Chemioter; 1985; 32(1):217-24. PubMed ID: 3830782
    [No Abstract]   [Full Text] [Related]  

  • 73. A study of the pharmacokinetics and tissue residues of an oral trimethoprim/sulphadiazine formulation in healthy pigs.
    Garwacki S; Lewicki J; Wiechetek M; Grys S; Rutkowski J; Zaremba M
    J Vet Pharmacol Ther; 1996 Dec; 19(6):423-30. PubMed ID: 8971670
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of administration route and dose alteration on sulfadiazine-trimethoprim plasma and intestinal concentrations in pigs.
    De Smet J; Croubels S; De Backer P; Devreese M
    Int J Antimicrob Agents; 2017 Dec; 50(6):707-714. PubMed ID: 28668685
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics of sulfonamides and trimethoprim in the donkey (Equus asinus).
    Oukessou M; Alsouss L
    Zentralbl Veterinarmed A; 1998 May; 45(4):191-8. PubMed ID: 9697419
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimicrobial susceptibility, growth kinetic and pathogenicity of thymidine-requiring Streptococcus species.
    Fu KP; Kimble EF; Coldreck RJ; Konopka EA
    Chemotherapy; 1984; 30(6):373-8. PubMed ID: 6335073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro studies with combinations of sulfamoxole and trimethoprim (co-trifamole).
    Grüneberg RN
    Curr Med Res Opin; 1982; 8(2):128-33. PubMed ID: 7105824
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim.
    Ekström B; Forsgren U; Ortengren B; Bergan T
    Infection; 1979; 7 Suppl 4():S359-66. PubMed ID: 389812
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma and urine concentrations of trimethoprim-sulphadiazine (co-trimazine) in children given one dose per day.
    Jodal U; Fellner H
    Scand J Infect Dis; 1988; 20(1):91-5. PubMed ID: 3363307
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Age-related alterations in trimethoprim-sulfadiazine disposition following oral or parenteral administration in calves.
    Guard CL; Schwark WS; Friedman DS; Blackshear P; Haluska M
    Can J Vet Res; 1986 Jul; 50(3):342-6. PubMed ID: 3742370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.